Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1498438

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1498438

Europe Dementia Treatment Market Size, Share & Trends Analysis Report By Type, By Dementia Drugs Route of Administration, By Dementia Drugs Distribution Channel, By Indication, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 172 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Dementia Treatment Market would witness market growth of 7.0% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Dementia Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,884.6 million by 2031. The UK market is exhibiting a CAGR of 6.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 7.8% during (2024 - 2031).

The economic impact of dementia is substantial, affecting not only individuals and families but also healthcare systems and societies at large. The cost of dementia care includes direct medical expenses, such as hospitalizations, medications, and long-term care, as well as indirect costs, such as lost productivity and informal caregiving.

The increasing prevalence of dementia is a primary driver of the growth in the dementia treatment market. In addition, developments in medical research and technology are serving as a driving force behind the market. Continuous research into the underlying mechanisms of dementia has led to the development of innovative therapeutic approaches, including disease-modifying therapies and targeted treatments.

Italy is experiencing significant demographic changes due to its rapidly aging population. The median age of Italy's population is one of the highest in Europe, and the proportion of elderly individuals is anticipated to continue increasing in the subsequent decades. The increasing incidence of dementia in the region has led to a greater emphasis on developing effective treatment strategies and enhancing healthcare infrastructure to manage the growing number of dementia patients. Thus, all the aforementioned elements will support the expansion of the market in the coming years.

Based on Type, the market is segmented into Diagnosis (Imaging Techniques, Cognitive Assessment Tools, Genetic Testing, Biomarker Analysis and Others) and Drugs (Cholinesterase Inhibitors, NMDA Receptor Antagonist, MAO Inhibitors, Combination Drug and Others). Based on Dementia Drugs Route of Administration, the market is segmented into Oral, Transdermal Patch, and Injectable. Based on Dementia Drugs Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on Indication, the market is segmented into Alzheimer's Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Eisai Co., Ltd.
  • Eli Lilly And Company
  • F. Hoffmann-La Roche Ltd.
  • Biogen, Inc.
  • AbbVie, Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline PLC (GSK)
  • Cipla Limited

Europe Dementia Treatment Market Report Segmentation

By Type

  • Diagnosis
    • Imaging Techniques
    • Cognitive Assessment Tools
    • Genetic Testing
    • Biomarker Analysis
    • Others
  • Drugs
    • Cholinesterase Inhibitors
    • NMDA Receptor Antagonist
    • MAO Inhibitors
    • Combination Drug
    • Others

By Dementia Drugs Route of Administration

  • Oral
  • Transdermal Patch
  • Injectable

By Dementia Drugs Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Indication

  • Alzheimer's Disease Dementia
  • Vascular Dementia
  • Lewy Body Dementia
  • Frontotemporal Dementia (FTD)
  • Parkinson Disease Dementia
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Dementia Treatment Market, by Type
    • 1.4.2 Europe Dementia Treatment Market, by Dementia Drugs Route of Administration
    • 1.4.3 Europe Dementia Treatment Market, by Dementia Drugs Distribution Channel
    • 1.4.4 Europe Dementia Treatment Market, by Indication
    • 1.4.5 Europe Dementia Treatment Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Europe Dementia Treatment Market by Type

  • 4.1 Europe Diagnosis Market by Country
  • 4.2 Europe Dementia Treatment Market by Diagnosis Type
    • 4.2.1 Europe Imaging Techniques Market by Country
    • 4.2.2 Europe Cognitive Assessment Tools Market by Country
    • 4.2.3 Europe Genetic Testing Market by Country
    • 4.2.4 Europe Biomarker Analysis Market by Country
    • 4.2.5 Europe Others Market by Country
  • 4.3 Europe Drugs Market by Country
  • 4.4 Europe Dementia Treatment Market by Drug Class
    • 4.4.1 Europe Cholinesterase Inhibitors Market by Country
    • 4.4.2 Europe NMDA Receptor Antagonist Market by Country
    • 4.4.3 Europe MAO Inhibitors Market by Country
    • 4.4.4 Europe Combination Drug Market by Country
    • 4.4.5 Europe Others Market by Country

Chapter 5. Europe Dementia Treatment Market by Dementia Drugs Route of Administration

  • 5.1 Europe Oral Market by Country
  • 5.2 Europe Transdermal Patch Market by Country
  • 5.3 Europe Injectable Market by Country

Chapter 6. Europe Dementia Treatment Market by Dementia Drugs Distribution Channel

  • 6.1 Europe Hospital Pharmacy Market by Country
  • 6.2 Europe Retail Pharmacy Market by Country
  • 6.3 Europe Online Pharmacy Market by Country

Chapter 7. Europe Dementia Treatment Market by Indication

  • 7.1 Europe Alzheimer's Disease Dementia Market by Country
  • 7.2 Europe Vascular Dementia Market by Country
  • 7.3 Europe Lewy Body Dementia Market by Country
  • 7.4 Europe Frontotemporal Dementia (FTD) Market by Country
  • 7.5 Europe Parkinson Disease Dementia Market by Country
  • 7.6 Europe Others Market by Country

Chapter 8. Europe Dementia Treatment Market by Country

  • 8.1 Germany Dementia Treatment Market
    • 8.1.1 Germany Dementia Treatment Market by Type
      • 8.1.1.1 Germany Dementia Treatment Market by Diagnosis Type
      • 8.1.1.2 Germany Dementia Treatment Market by Drug Class
    • 8.1.2 Germany Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.1.3 Germany Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.1.4 Germany Dementia Treatment Market by Indication
  • 8.2 UK Dementia Treatment Market
    • 8.2.1 UK Dementia Treatment Market by Type
      • 8.2.1.1 UK Dementia Treatment Market by Diagnosis Type
      • 8.2.1.2 UK Dementia Treatment Market by Drug Class
    • 8.2.2 UK Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.2.3 UK Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.2.4 UK Dementia Treatment Market by Indication
  • 8.3 France Dementia Treatment Market
    • 8.3.1 France Dementia Treatment Market by Type
      • 8.3.1.1 France Dementia Treatment Market by Diagnosis Type
      • 8.3.1.2 France Dementia Treatment Market by Drug Class
    • 8.3.2 France Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.3.3 France Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.3.4 France Dementia Treatment Market by Indication
  • 8.4 Russia Dementia Treatment Market
    • 8.4.1 Russia Dementia Treatment Market by Type
      • 8.4.1.1 Russia Dementia Treatment Market by Diagnosis Type
      • 8.4.1.2 Russia Dementia Treatment Market by Drug Class
    • 8.4.2 Russia Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.4.3 Russia Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.4.4 Russia Dementia Treatment Market by Indication
  • 8.5 Spain Dementia Treatment Market
    • 8.5.1 Spain Dementia Treatment Market by Type
      • 8.5.1.1 Spain Dementia Treatment Market by Diagnosis Type
      • 8.5.1.2 Spain Dementia Treatment Market by Drug Class
    • 8.5.2 Spain Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.5.3 Spain Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.5.4 Spain Dementia Treatment Market by Indication
  • 8.6 Italy Dementia Treatment Market
    • 8.6.1 Italy Dementia Treatment Market by Type
      • 8.6.1.1 Italy Dementia Treatment Market by Diagnosis Type
      • 8.6.1.2 Italy Dementia Treatment Market by Drug Class
    • 8.6.2 Italy Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.6.3 Italy Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.6.4 Italy Dementia Treatment Market by Indication
  • 8.7 Rest of Europe Dementia Treatment Market
    • 8.7.1 Rest of Europe Dementia Treatment Market by Type
      • 8.7.1.1 Rest of Europe Dementia Treatment Market by Diagnosis Type
      • 8.7.1.2 Rest of Europe Dementia Treatment Market by Drug Class
    • 8.7.2 Rest of Europe Dementia Treatment Market by Dementia Drugs Route of Administration
    • 8.7.3 Rest of Europe Dementia Treatment Market by Dementia Drugs Distribution Channel
    • 8.7.4 Rest of Europe Dementia Treatment Market by Indication

Chapter 9. Company Profiles

  • 9.1 Eisai Co., Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Trails and Approval:
    • 9.1.6 SWOT Analysis
  • 9.2 Eli Lilly And Company
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Acquisition and Mergers:
    • 9.2.6 SWOT Analysis
  • 9.3 F. Hoffmann-La Roche Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
    • 9.3.6 SWOT Analysis
  • 9.4 Biogen, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 SWOT Analysis
  • 9.5 AbbVie, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 SWOT Analysis
  • 9.6 Novartis AG
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 SWOT Analysis
  • 9.7 Sun Pharmaceutical Industries Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 SWOT Analysis
  • 9.8 Takeda Pharmaceutical Company Limited
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 SWOT Analysis
  • 9.9 GlaxoSmithKline PLC (GSK)
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 SWOT Analysis
  • 9.10. Cipla Limited
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expense
    • 9.10.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Europe Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 2 Europe Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 3 Europe Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 4 Europe Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 5 Europe Diagnosis Market by Country, 2020 - 2023, USD Million
  • TABLE 6 Europe Diagnosis Market by Country, 2024 - 2031, USD Million
  • TABLE 7 Europe Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 8 Europe Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 9 Europe Imaging Techniques Market by Country, 2020 - 2023, USD Million
  • TABLE 10 Europe Imaging Techniques Market by Country, 2024 - 2031, USD Million
  • TABLE 11 Europe Cognitive Assessment Tools Market by Country, 2020 - 2023, USD Million
  • TABLE 12 Europe Cognitive Assessment Tools Market by Country, 2024 - 2031, USD Million
  • TABLE 13 Europe Genetic Testing Market by Country, 2020 - 2023, USD Million
  • TABLE 14 Europe Genetic Testing Market by Country, 2024 - 2031, USD Million
  • TABLE 15 Europe Biomarker Analysis Market by Country, 2020 - 2023, USD Million
  • TABLE 16 Europe Biomarker Analysis Market by Country, 2024 - 2031, USD Million
  • TABLE 17 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 18 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 19 Europe Drugs Market by Country, 2020 - 2023, USD Million
  • TABLE 20 Europe Drugs Market by Country, 2024 - 2031, USD Million
  • TABLE 21 Europe Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 22 Europe Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 23 Europe Cholinesterase Inhibitors Market by Country, 2020 - 2023, USD Million
  • TABLE 24 Europe Cholinesterase Inhibitors Market by Country, 2024 - 2031, USD Million
  • TABLE 25 Europe NMDA Receptor Antagonist Market by Country, 2020 - 2023, USD Million
  • TABLE 26 Europe NMDA Receptor Antagonist Market by Country, 2024 - 2031, USD Million
  • TABLE 27 Europe MAO Inhibitors Market by Country, 2020 - 2023, USD Million
  • TABLE 28 Europe MAO Inhibitors Market by Country, 2024 - 2031, USD Million
  • TABLE 29 Europe Combination Drug Market by Country, 2020 - 2023, USD Million
  • TABLE 30 Europe Combination Drug Market by Country, 2024 - 2031, USD Million
  • TABLE 31 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 32 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 33 Europe Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 34 Europe Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 35 Europe Oral Market by Country, 2020 - 2023, USD Million
  • TABLE 36 Europe Oral Market by Country, 2024 - 2031, USD Million
  • TABLE 37 Europe Transdermal Patch Market by Country, 2020 - 2023, USD Million
  • TABLE 38 Europe Transdermal Patch Market by Country, 2024 - 2031, USD Million
  • TABLE 39 Europe Injectable Market by Country, 2020 - 2023, USD Million
  • TABLE 40 Europe Injectable Market by Country, 2024 - 2031, USD Million
  • TABLE 41 Europe Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 42 Europe Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 43 Europe Hospital Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 44 Europe Hospital Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 45 Europe Retail Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 46 Europe Retail Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 47 Europe Online Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 48 Europe Online Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 49 Europe Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 50 Europe Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 51 Europe Alzheimer's Disease Dementia Market by Country, 2020 - 2023, USD Million
  • TABLE 52 Europe Alzheimer's Disease Dementia Market by Country, 2024 - 2031, USD Million
  • TABLE 53 Europe Vascular Dementia Market by Country, 2020 - 2023, USD Million
  • TABLE 54 Europe Vascular Dementia Market by Country, 2024 - 2031, USD Million
  • TABLE 55 Europe Lewy Body Dementia Market by Country, 2020 - 2023, USD Million
  • TABLE 56 Europe Lewy Body Dementia Market by Country, 2024 - 2031, USD Million
  • TABLE 57 Europe Frontotemporal Dementia (FTD) Market by Country, 2020 - 2023, USD Million
  • TABLE 58 Europe Frontotemporal Dementia (FTD) Market by Country, 2024 - 2031, USD Million
  • TABLE 59 Europe Parkinson Disease Dementia Market by Country, 2020 - 2023, USD Million
  • TABLE 60 Europe Parkinson Disease Dementia Market by Country, 2024 - 2031, USD Million
  • TABLE 61 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 62 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 63 Europe Dementia Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 64 Europe Dementia Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 65 Germany Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 66 Germany Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 67 Germany Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 68 Germany Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 69 Germany Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 70 Germany Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 71 Germany Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 72 Germany Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 73 Germany Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 74 Germany Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 75 Germany Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 76 Germany Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 77 Germany Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 78 Germany Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 79 UK Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 80 UK Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 81 UK Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 82 UK Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 83 UK Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 84 UK Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 85 UK Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 86 UK Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 87 UK Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 88 UK Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 89 UK Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 90 UK Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 91 UK Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 92 UK Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 93 France Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 94 France Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 95 France Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 96 France Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 97 France Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 98 France Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 99 France Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 100 France Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 101 France Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 102 France Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 103 France Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 104 France Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 105 France Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 106 France Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 107 Russia Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 108 Russia Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 109 Russia Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 110 Russia Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 111 Russia Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 112 Russia Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 113 Russia Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 114 Russia Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 115 Russia Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 116 Russia Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 117 Russia Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 118 Russia Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 119 Russia Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 120 Russia Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 121 Spain Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 122 Spain Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 123 Spain Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 124 Spain Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 125 Spain Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 126 Spain Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 127 Spain Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 128 Spain Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 129 Spain Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 130 Spain Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 131 Spain Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 132 Spain Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 133 Spain Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 134 Spain Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 135 Italy Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 136 Italy Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 137 Italy Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 138 Italy Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 139 Italy Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 140 Italy Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 141 Italy Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 142 Italy Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 143 Italy Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 144 Italy Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 145 Italy Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 146 Italy Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 147 Italy Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 148 Italy Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 149 Rest of Europe Dementia Treatment Market, 2020 - 2023, USD Million
  • TABLE 150 Rest of Europe Dementia Treatment Market, 2024 - 2031, USD Million
  • TABLE 151 Rest of Europe Dementia Treatment Market by Type, 2020 - 2023, USD Million
  • TABLE 152 Rest of Europe Dementia Treatment Market by Type, 2024 - 2031, USD Million
  • TABLE 153 Rest of Europe Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
  • TABLE 154 Rest of Europe Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
  • TABLE 155 Rest of Europe Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
  • TABLE 156 Rest of Europe Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
  • TABLE 157 Rest of Europe Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
  • TABLE 158 Rest of Europe Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
  • TABLE 159 Rest of Europe Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
  • TABLE 160 Rest of Europe Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
  • TABLE 161 Rest of Europe Dementia Treatment Market by Indication, 2020 - 2023, USD Million
  • TABLE 162 Rest of Europe Dementia Treatment Market by Indication, 2024 - 2031, USD Million
  • TABLE 163 Key Information - Eisai Co., Ltd.
  • TABLE 164 Key Information - Eli Lilly And Company
  • TABLE 165 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 166 Key Information - Biogen, Inc.
  • TABLE 167 Key information - AbbVie, Inc.
  • TABLE 168 Key Information - Novartis AG
  • TABLE 169 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 170 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 171 Key Information - GlaxoSmithKline PLC
  • TABLE 172 Key Information - Cipla Limited
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!